ReShape Lifesciences prices 1.054M shares at $2.50 in public offering

ReShape Lifesciences (RSLS) announced the pricing of its public offering of 1,054,604 shares of common stock at a public offering price of $2.50 per share. Gross proceeds from the offering are expected to be approximately $2.6M before deducting placement agent fees and other offering expenses. The offering is expected to close on or about June 9, 2025, subject to the satisfaction of customary closing conditions. Maxim Group is acting as sole placement agent in connection with the offering.